Nektar Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts that cover Nektar Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $146.67, which forecasts a 69.64% increase in the stock price over the next year. The lowest target is $95 and the highest is $185.

Price Target: $146.67 (+69.64%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$95	$146.67	$151	$185
Change	+9.88%	+69.64%	+74.65%	+113.97%

Analyst Ratings

The average analyst rating for Nektar Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	5	5	5	5	6	6
Buy	1	1	1	1	0	0
Hold	0	0	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Samantha Semenkow Citigroup	Citigroup	Strong Buy Maintains $123 → $151	Strong Buy	Maintains	$123 → $151	+74.65%	Apr 21, 2026
Martin Fan Wedbush	Wedbush	Hold Maintains $70 → $95	Hold	Maintains	$70 → $95	+9.88%	Apr 21, 2026
Arthur He HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $165 → $185	Strong Buy	Maintains	$165 → $185	+113.97%	Apr 20, 2026
Julian Harrison BTIG	BTIG	Strong Buy Maintains $151 → $178	Strong Buy	Maintains	$151 → $178	+105.88%	Apr 20, 2026
Martin Fan Wedbush	Wedbush	Hold Initiates $70	Hold	Initiates	$70	-19.04%	Mar 24, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

42.20M

from 55.23M

-23.60%

from 55.23M

Revenue Next Year

36.64M

from 42.20M

-13.18%

from 42.20M

EPS This Year

-10.12

from -9.73

EPS Next Year

-12.38

from -10.12

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	101.91M	92.06M	90.12M	98.43M	55.23M	42.20M	36.64M
Revenue Growth	-33.36%	-9.67%	-2.10%	9.22%	-43.89%	-23.60%	-13.18%
EPS	-42.90	-29.55	-21.79	-8.68	-9.73	-10.12	-12.38
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	12	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	47.7M	48.7M
Avg	42.2M	36.6M
Low	23.5M	7.9M

Revenue Growth

Revenue Growth	2026	2027
High	-13.7%	15.5%
Avg	-23.6%	-13.2%
Low	-57.4%	-81.2%

EPS Forecast

EPS	2026	2027
High	-7.77	-9.19
Avg	-10.12	-12.38
Low	-13.26	-15.24

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.